Interprofessional Webinar Series:
Pain and Substance Use Disorder in a Complicated “Survivor”
This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.
Funding Disclosure: No commercial funding has been accepted for the activity.
Date and Time: July 20, 2017, 12:30 PM – 1:30 PM ET (Live)
Location: Online at http://www.mjhspalliativeinstitute.org/e-learning/
Speaker Name and Title:
Russell K. Portenoy, MD
Moderator, Executive Director
MJHS Institute for Innovation in Palliative Care;
Chief Medical Officer, MJHS Hospice & Palliative Care
Mara Lugassy, MD
Hospice Medical Director
Adam Schoenfarber, LMSW
Social Work Team Manager
Wanda Youdelman, RN, MSN, CHPN
Staff Development Manager
Rabbi Charles Rudansky
Director of Pastoral Care
Purpose: The purpose of this webinar is to describe the interdisciplinary approach to the assessment and management of chronic pain in a patient with an indolent cancer and a history of substance use disorder.
Participants will be able to:
- Define cancer survivor
- Perform a comprehensive assessment of the cancer patient with indeterminate prognosis and chronic pain in terms of the benefits and burdens of symptom control therapies
- Select patients for opioid therapy, and undertake this treatment in a manner that manages the risk of drug abuse outcomes
Why Do I Need to Know This?
The term “cancer survivor” has varied meanings and can refer to patients with active but indolent disease. The causes of chronic pain in this population are protean, and management is complicated by patient goals that usually include aggressive disease management and functional restoration, as well as symptom control. The use of opioid therapy is challenging given these goals, particularly if the patient also has a history of substance use disorder. The assessment and management of pain in a complex patient who has active cancer but is a survivor, and who has chronic pain but is a high-risk candidate for long-term opioid therapy, has important lessons for every discipline involved in palliative care.
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students.
Criteria for Successful Completion:
- Attendance at entire session (mandatory for nurses and pharmacists)
- Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs and nurses)
- Submission of completed Verification of Continuing Education Participation Form, Program Evaluation Form, and CE Validation Form (mandatory for pharmacists). Pharmacists must email all three forms to PalliativeInstitute@mjhs.org or fax forms to 212-649-5544 within 45 days of webinar date.
Continuing Education Credits: 1.0
Continuing Education Accreditation:
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.
NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.
NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.
Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.
Individual: $25 (includes CME/CE certificate)
Group: $95 + $5 per CME/CE certificate
Registration fees for webinars are not refundable.
System Requirements for Computers and Mobile Devices:
Russell K. Portenoy, MD, Moderator and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP for research support.
Mara Lugassy, MD, Adam Schoenfarber, LMSW, Wanda Youdelman, RN, MSN, CHPN, and Rabbi Charles Rudansky have no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny